Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Offringa

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
Cancer Research|December 5, 2000
Superior tumor protection induced by a cellular vaccine carrying a tumor-specific T helper epitope by genetic exchange of the class II-associated invariant chain peptideJ van Bergen, M Camps, R Offringa, et al.
The Journal of Biological Chemistry|October 27, 1995
Purification and functional analysis of the Mycobacterium leprae thioredoxin/thioredoxin reductase hybrid proteinB Wieles, J van Noort, J W Drijfhout, et al.
Current Opinion in Immunology|September 28, 2000
Design and evaluation of antigen-specific vaccination strategies against cancerR Offringa, S H van der Burg, F Ossendorp, et al.
Annals of the New York Academy of Sciences|July 27, 2000
p53: a potential target antigen for immunotherapy of cancerR Offringa, M P Vierboom, S H van der Burg, et al.
Development (Cambridge, England)|October 31, 2001
An Arabidopsis Minute-like phenotype caused by a semi-dominant mutation in a RIBOSOMAL PROTEIN S5 geneD Weijers, M Franke-van Dijk, R J Vencken, et al.
Nucleic Acids Research|December 9, 1988
Similar effects of adenovirus E1A and glucocorticoid hormones on the expression of the metalloprotease stromelysinR Offringa, A M Smits, A Houweling, et al.
Immunology Letters|September 21, 2000
Importance of CD4(+) T helper cell responses in tumor immunityF Ossendorp, R E Toes, R Offringa, et al.
Nature|June 12, 1998
T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactionsS P Schoenberger, R E Toes, E I van der Voort, et al.
Seminars in Immunology|November 25, 1998
CD40-CD40Ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunityR E Toes, S P Schoenberger, E I van der Voort, et al.
The Journal of Experimental Medicine|August 22, 2000
Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28van Hall T, A Sijts, M Camps, et al.
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Cancer Research|December 5, 2000
Superior tumor protection induced by a cellular vaccine carrying a tumor-specific T helper epitope by genetic exchange of the class II-associated invariant chain peptideJ van Bergen, M Camps, R Offringa, et al.
The Journal of Biological Chemistry|October 27, 1995
Purification and functional analysis of the Mycobacterium leprae thioredoxin/thioredoxin reductase hybrid proteinB Wieles, J van Noort, J W Drijfhout, et al.
Current Opinion in Immunology|September 28, 2000
Design and evaluation of antigen-specific vaccination strategies against cancerR Offringa, S H van der Burg, F Ossendorp, et al.
Annals of the New York Academy of Sciences|July 27, 2000
p53: a potential target antigen for immunotherapy of cancerR Offringa, M P Vierboom, S H van der Burg, et al.
Development (Cambridge, England)|October 31, 2001
An Arabidopsis Minute-like phenotype caused by a semi-dominant mutation in a RIBOSOMAL PROTEIN S5 geneD Weijers, M Franke-van Dijk, R J Vencken, et al.
Nucleic Acids Research|December 9, 1988
Similar effects of adenovirus E1A and glucocorticoid hormones on the expression of the metalloprotease stromelysinR Offringa, A M Smits, A Houweling, et al.
Immunology Letters|September 21, 2000
Importance of CD4(+) T helper cell responses in tumor immunityF Ossendorp, R E Toes, R Offringa, et al.
Nature|June 12, 1998
T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactionsS P Schoenberger, R E Toes, E I van der Voort, et al.
Seminars in Immunology|November 25, 1998
CD40-CD40Ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunityR E Toes, S P Schoenberger, E I van der Voort, et al.
The Journal of Experimental Medicine|August 22, 2000
Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28van Hall T, A Sijts, M Camps, et al.
Pageof 10